Overview

Intrauterine Lidocaine for Laminaria

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
0
Participant gender:
Female
Summary
This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocaine in addition to a paracervical block will experience less pain than women who receive only a paracervical block.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- Can sign informed consent

- Healthy pregnant females

- Weight over 45kg

- Seeking abortion by dilation and evacuation in the second trimester of pregnancy

- Gestational age 14-24 weeks confirmed by clinic ultrasound

Exclusion Criteria:

- Known allergy or previous reaction to lidocaine, bupivicaine or other anesthetic agent

- Known allergy or previous reaction to ibuprofen or other NSAID